Gyncare MUDr. Michael Svec s.r.o.

The research team at Gyncare MUDr. Michael Svec s.r.o. is conducting studies that target bacterial vaginosis and compare the effectiveness of new antimicrobial agents such as furazidin with established treatments like clindamycin.

• Comparative efficacy of oral versus topical antibiotics
• Safety and tolerability of novel vaginal tablets
• Microbiological outcomes in recurrent infections

These investigations aim to improve therapeutic options for women experiencing bacterial infections of the genital tract.

Clinical trials at the clinic focus on conditions such as urinary incontinence, endometriosis-related pain, and the broader effects of oral contraception on women's health.

• Evaluation of new pharmacologic agents for stress urinary incontinence
• Pain management strategies for endometriosis sufferers
• Impact of hormonal contraceptives on reproductive‑system outcomes

The goal is to enhance quality of life for patients dealing with urogenital disorders and to provide safer, more effective treatment alternatives.

A key area of investigation examines how hormonal contraceptive use influences bone mineral density in the lumbar spine of adolescent and adult women.

• Long‑term bone health monitoring in contraceptive users
• Assessment of musculoskeletal safety across different hormone formulations
• Correlation of neural hormonal pathways with skeletal outcomes

These studies seek to ensure that reproductive health interventions do not compromise skeletal integrity.